Bio-Rad QX200 Droplet Digital PCR (ddPCR) System
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health intends to award a firm-fixed-price purchase order to Bio-rad Laboratories, Inc. for the acquisition of the QX200 Droplet Digital PCR system under solicitation 75N98026Q01194. This procurement is being conducted as a sole-source acquisition because Bio-Rad is the only manufacturer of this specific proprietary droplet-based digital PCR technology, which is required for the absolute quantification of nucleic acid targets with high precision and sensitivity. While this is not a request for competitive quotations, the government is allowing interested responsible sources, including various small business concerns, to submit capability statements demonstrating their ability to provide an equivalent system. All responses must be submitted to the primary point of contact by 9:00 a.m. EDT on September 17, 2026. If no acceptable alternatives are identified, the award is expected to be issued approximately five days after the closing date.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Notice of Intent: Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.
(75N98026Q01194)
The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bio-rad Laboratories, Inc. under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bio-rad Laboratories, Inc. for the acquisition of Bio-Rad QX200 Droplet Digital PCR (ddPCR) System.
Bio-Rad Laboratories is the sole manufacturer and provider of the QX200 ddPCR system and its proprietary droplet-based digital PCR technology. The system employs a unique microfluidic droplet partitioning approach that enables absolute quantification of nucleic acid targets with high precision and sensitivity.
No alternative commercially available system provides the specific combination of capabilities.
This notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.
A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.
Responses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 17, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS